This Article Full Text Full Text (PDF) All Versions of this Article: 2008-0044OCv1 39/4/390    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Kalin, T. V. Articles by Kalinichenko, V. V. PubMed PubMed Citation Articles by Kalin, T. V. Articles by Kalinichenko, V. V.

Pulmonary Mastocytosis and Enhanced Lung Inflammation in Mice Heterozygous Null for the Foxf1 Gene

¹ Division of Pulmonary Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, Ohio; and ² Department of Medicine, University of Chicago, Chicago, Illinois

Correspondence and requests for reprints should be addressed to Vladimir V. Kalinichenko, Division of Pulmonary Biology, Cincinnati Children's Hospital Research Foundation, 3333 Burnet Ave., MLC 7009, Cincinnati, OH 45229. E-mail: Vladimir.Kalinichenko{at}cchmc.org

The Forkhead Box f1 (Foxf1) transcriptional factor (previously known as HFH-8 or Freac-1) is expressed in endothelial and smooth muscle cells in the embryonic and adult lung. To assess effects of Foxf1 during lung injury, we used CCl₄ and butylated hydroxytoluene (BHT) injury models. Foxf1^+/– mice developed severe airway obstruction and bronchial edema, associated with increased numbers of pulmonary mast cells and increased mast cell degranulation after injury. Pulmonary inflammation in Foxf1^+/– mice was associated with diminished expression of Foxf1, increased mast cell tryptase, and increased expression of CXCL12, the latter being essential for mast cell migration and chemotaxis. After ovalbumin (OVA) sensitization and OVA challenge, increased lung inflammation, airway hyperresponsiveness to methacholine, and elevated expression of CXCL12 were observed in Foxf1^+/– mice. During lung development, Foxf1^+/– embryos displayed a marked increase in pulmonary mast cells before birth, and this was associated with increased CXCL12 levels in the lung. Expression of a doxycycline-inducible Foxf1 dominant-negative transgene in primary cultures of lung endothelial cells increased CXCL12 expression in vitro. Foxf1 haploinsufficiency caused pulmonary mastocytosis and enhanced pulmonary inflammation after chemically induced or allergen-mediated lung injury, indicating an important role for Foxf1 in the pathogenesis of pulmonary inflammatory responses.

Key Words: Foxf1 • CXCL12 • SDF-1 • mast cells • lung injury

CLINICAL RELEVANCE Foxf1 haploinsufficiency caused pulmonary mastocytosis and enhanced pulmonary inflammation after chemically induced or allergen-mediated lung injury, indicating an important role for Foxf1 in the pathogenesis of pulmonary inflammatory responses.